MedTrace Logo

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

NCT04710212 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 168

Last updated 2022-04-06

No results posted yet for this study

Summary

This is a prospective, observational cohort study to assess the frequency with which neutropenic patients with hematologic malignancies and hematopoietic cell transplant (HCT) recipients are colonized with fluoroquinolone-resistant Enterobacterales (FQRE) and the clinical impact of FQRE colonization.

Conditions

  • Hematologic Malignancy
  • Leukemia, Acute
  • Neutropenia
  • Bloodstream Infection

Interventions

OTHER

No intervention.

Observational study with no intervention.

Sponsors & Collaborators

  • Duke University

    lead OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

Principal Investigators

  • Michael Satlin · Weill Medical College of Cornell University

  • Vance G Fowler, MD · Duke Clinical Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-12
Primary Completion
2021-12-30
Completion
2022-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710212 on ClinicalTrials.gov